Fredrika Killander
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 16, 2026
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.
Journal: BMJ open
Published: August 27, 2025
Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer.
Journal: Cancer research communications
Published: August 04, 2025
Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial.
Journal: Breast cancer research and treatment
Published: March 03, 2025
Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer.
Journal: Journal of the National Cancer Institute
Published: September 21, 2024
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2024
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT: a randomized clinical trial with long-term follow-up.
Journal: BMC cancer
Published: September 06, 2024
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer: results from a population-based cohort.
Journal: Breast cancer research and treatment
Published: May 28, 2024
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.
Journal: Breast cancer research : BCR
Published: April 20, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
Journal: Journal for immunotherapy of cancer
Published: March 17, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.
Journal: Molecular oncology
Published: November 08, 2022
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2022
Last Updated: 09/26/2026